Financhill
Sell
28

CRNX Quote, Financials, Valuation and Earnings

Last price:
$53.63
Seasonality move :
-9.59%
Day range:
$51.73 - $54.25
52-week range:
$33.67 - $62.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.96x
Volume:
1.8M
Avg. volume:
753.6K
1-year change:
55.12%
Market cap:
$5B
Revenue:
$4M
EPS (TTM):
-$3.73

Earnings Data

Next earnings date for CRNX
Feb 28
2025
Most recent earnings per share
-$0.96
Missed by $0.05
(Nov 12/2024)
Consensus Estimate
-$0.91
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRNX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $700K -- -- -$0.89 --
11/12/2024 Q3 $239.9K -- -$0.96 -$0.91 -$0.05
08/08/2024 Q2 $467.3K $399K -$0.94 -$0.86 -$0.08
05/09/2024 Q1 $181.8K $640K -$0.93 -$0.81 -$0.12
02/28/2024 Q4 $182.9K -- -$0.90 -$0.87 -$0.03
11/07/2023 Q3 -- -- -$1.01 -$0.88 -$0.13
08/08/2023 Q2 -- -- -$0.94 -$0.85 -$0.09
05/04/2023 Q1 -- -- -$0.85 -$0.83 -$0.02
02/28/2023 Q4 -- -- -$0.84 -$0.85 $0.01
11/14/2022 Q3 -- -- -$0.78 -$0.83 $0.05
08/12/2022 Q2 -- -- -$0.81 -$0.66 -$0.15
05/12/2022 Q1 -- -- -$0.73 -$0.45 -$0.28
03/30/2022 Q4 -- -- -$0.68 -$0.63 -$0.05
11/05/2021 Q3 -- -- -$0.73 -$0.73 $0.00
08/10/2021 Q2 -- -- -$0.70 -$0.63 -$0.07
05/06/2021 Q1 -- -- -$0.69 -$0.66 -$0.03
03/30/2021 Q4 -- -- -$0.66 -$0.59 -$0.07
11/06/2020 Q3 -- -- -$0.56 -$0.52 -$0.04
08/07/2020 Q2 -- -- -$0.53 -$0.56 $0.03
05/08/2020 Q1 -- -- -$0.71 -$0.65 -$0.06
03/09/2020 Q4 -- -- -$0.60 -$0.63 $0.03
11/12/2019 Q3 -- -- -$0.60 -$0.53 -$0.07
08/13/2019 Q2 -- -- -$0.51 -$0.45 -$0.06
05/13/2019 Q1 -- -- -$0.37 -$0.41 $0.04
02/13/2019 Q4 -- -- -$0.35 -- --
11/13/2018 Q3 -- -- -$0.38 -- --
08/30/2018 Q2 -- -- -$0.25 -- --
03/31/2018 Q1 -- -- -$0.25 -- --
12/31/2017 Q4 -- -- -$0.18 -- --
09/30/2017 Q3 -- -- -$0.17 -- --
06/30/2017 Q2 -- -- -$0.12 -- --
03/31/2017 Q1 -- -- -$0.19 -- --

Crinetics Pharmaceuticals Earnings Questions

  • How Much did Crinetics Pharmaceuticals Generate in Revenue Last Quarter?

    Crinetics Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Crinetics Pharmaceuticals Beat Earnings Last Quarter?

    Crinetics Pharmaceuticals announced earnings per share of -$0.96 which represents a miss of analyst forecast a -$0.91 per share.

  • Is Crinetics Pharmaceuticals Profitable?

    Crinetics Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Crinetics Pharmaceuticals EPS Next Year?

    Crinetics Pharmaceuticals's earnings are forecast to decrease from -$3.69 per share to -$3.65 per share next year representing a decrease of -1.16%.

  • When is Crinetics Pharmaceuticals's Earnings Date?

    Crinetics Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock